South San Francisco, CA, United States of America

Natarajan Vijayasankaran

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Natarajan Vijayasankaran: Innovator in Cell Culture Technologies

Introduction

Natarajan Vijayasankaran is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of biotechnology, particularly in cell culture technologies. With a total of 5 patents, his work has advanced the methods used for polypeptide production.

Latest Patents

His latest patents focus on cell culture compositions that incorporate antioxidants. These innovations provide methods for polypeptide production from cells, enhancing the efficiency and effectiveness of cell culturing processes. The compositions include therapeutic polypeptides produced through these advanced methods, showcasing the potential for significant applications in medical and pharmaceutical fields.

Career Highlights

Throughout his career, Natarajan has worked with leading companies in the biotechnology sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative approaches to cell culture and polypeptide production.

Collaborations

Natarajan has collaborated with notable professionals in his field, including Steven J. Meier and Sharat Varma. These partnerships have contributed to the success of his projects and the advancement of biotechnology.

Conclusion

Natarajan Vijayasankaran's contributions to cell culture technologies and polypeptide production highlight his role as an influential inventor in the biotechnology industry. His work continues to pave the way for advancements that can benefit various applications in healthcare and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…